Executive Team

Daniel J. Vukelich, Esq. is the President/CEO of the Association of Medical Device Reprocessors (AMDR). Mr. Vukelich has been with AMDR since 2000. AMDR represents the companies that conduct a majority of the commercial “single=-use” medical device reprocessing and re-manufacturing done in North American and Europe today. Mr. Vukelich joined AMDR in the same year the U.S. Food and Drug Administration (FDA) issued requirements putting reprocessors on equal regulatory footing with medical device manufacturers. During his time at AMDR, he has worked with regulators and legislators as they implemented the federal Medical Device User Fee and Modernization Act of 2002 (MDUFMA), the Medical Devices Technical Corrections Act of 2004 (MDTCA), the Medical Device User Fee Stabilization Act of 2005 (MDUFSA), the FDA Amendments of 2007, the comprehensive healthcare insurance reform legislation of 2009-2010 and the comprehensive European Union Medical Device Regulation of 2016.

Mr. Vukelich has overseen a team of state contract lobbyists and has beaten back every legislative attempt brought by some in the original equipment manufacturing industry aimed at reprocessing to date. Mr. Vukelich also has represents the device reprocessing industry before state regulatory agencies and international bodies (including Canada, the European Union, Japan and others).

In 2000, the nation’s third-party reprocessing industry saved U.S. hospitals $20 million in device acquisition costs. Today, AMDR’s members save U.S. hospitals over $300 million a year in device acquisition and disposal costs. AMDR’s members now also serve a majority of the nation’s “Honor Roll” hospitals, as listed by U.S. News & World Report and a majority of German academic medical centers.

With over 17 years experience working on medical device reprocessing issues, Mr. Vukelich is intimately familiar with the legal, regulatory, public relations and political issues surrounding the reprocessing industry. Prior to joining AMDR, Mr. Vukelich gained experience working for a non-profit citizens’ advocacy group and worked on a U.S. Senate campaign. He is a member of the Association for the Advancement of Medical Instrumentation (AAMI) and the American Society of Association Executives, among other groups, and is a Certified Association Executive (CAE) through ASAE, and a former National Debate champion (1996). Mr. Vukelich received a B.A. in Political Science and Public Communication with Pi Sigma Alpha honors from the American University in Washington, DC and his Juris Doctor degree from the American University’s Washington College of Law. He is a native of Minneapolis and a member of the Florida and District of Columbia Bars.

Mr. Weeda is an attorney with Olsson Frank Weeda Terman Matz PC in Washington, DC and serves as AMDR’s outside regulatory and general counsel. Mr. Weeda’s practice focuses on FDA-related issues, representing medical device, biologics, pharmaceutical and agriculture-related businesses, including manufacturers, distributors and importers.

Mr. Weeda’s law firm has provided counsel to AMDR since its inception in the late 1990s.

Beth Cherry oversees communications efforts for AMDR, and hails from a background in PR and marketing, most recently garnering press for clients for the past decade at her marketing and PR consulting practice, B. Cherry Communications. Prior to that, Ms. Cherry was Director of Marketing for an education technology association, and has work experience ranging from start up companies and non-profits to the publishing sector, where she worked for Smithsonian Magazine. Ms. Cherry graduated from the University of Maryland with a B.A. in History and a B.A. in Anthropology. She currently resides in the Washington, D.C. area.